These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38989428)

  • 1. Prognosis for local radical treatment in patients with esophageal squamous cell carcinoma with low-risk oligometastatic recurrence after curative resection: a retrospective cohort study.
    Li T; Ke D; Fu X; Dai Y; Lin J; Anker CJ; Bai Z; Li J
    J Gastrointest Oncol; 2024 Jun; 15(3):807-817. PubMed ID: 38989428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligometastatic recurrence as a prognostic factor after curative resection of esophageal squamous cell carcinoma.
    Morinaga T; Iwatsuki M; Yamashita K; Harada K; Kurashige J; Nagai Y; Iwagami S; Baba Y; Yoshida N; Baba H
    Surg Today; 2021 May; 51(5):798-806. PubMed ID: 33130992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between the treatment course and prognosis of oligometastasis after esophageal squamous cell carcinoma resection.
    Matsumoto C; Iwatsuki M; Morinaga T; Horinouchi T; Hara Y; Baba Y; Miyamoto Y; Yoshida N; Baba H
    Surg Today; 2024 Aug; 54(8):927-934. PubMed ID: 38583108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
    Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
    Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of lymphadenectomy on lymph node recurrence after performing various treatments for esophageal squamous cell carcinoma.
    Shigeno T; Hoshino A; Matsunaga S; Shimano R; Ishibashi N; Shinohara H; Shiobara H; Tomii C; Saito K; Fujiwara N; Sato Y; Kawada K; Tokunaga M; Kinugasa Y
    BMC Surg; 2022 May; 22(1):171. PubMed ID: 35545769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic invasion is a prognostic factor of pathological N0 esophageal squamous cell carcinoma.
    Toriumi T; Yagi K; Ri M; Yajima S; Okumura Y; Aikou S; Yamashita H; Nomura S; Seto Y
    Dis Esophagus; 2022 Jul; 35(7):. PubMed ID: 34937084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
    Chen J; Yin W; Yao H; Gu W
    Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive value of log odds of positive lymph nodes for the prognosis of patients with node-negative squamous cell carcinoma of the thoracic esophagus after radical esophagectomy].
    Yang M; Zhang H; Huo X; Chen C; Yu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):535-9. PubMed ID: 27215521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Lymphangio vascular (V) and perineural (N) invasion on survival of patients with resected esophageal squamous cell carcinoma (ESCC): a single-center retrospective study.
    Xie C; Chen Z; Xu J; Meng Z; Huang Z; Lin J
    PeerJ; 2022; 10():e12974. PubMed ID: 35256918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for early local lymph node recurrence of thoracic ESCC after McKeown esophagectomy.
    Dai L; Yang YB; Wu YY; Fu H; Yan WP; Lin Y; Wang ZM; Chen KN
    Front Surg; 2022; 9():1043755. PubMed ID: 36684130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
    Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
    BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma.
    Kaida H; Yasuda T; Shiraishi O; Kato H; Kimura Y; Hanaoka K; Yamada M; Matsukubo Y; Tsurusaki M; Kitajima K; Hattori S; Ishii K
    BMC Cancer; 2022 Nov; 22(1):1176. PubMed ID: 36376801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.
    Kosuga T; Shiozaki A; Fujiwara H; Ichikawa D; Okamoto K; Komatsu S; Otsuji E
    World J Surg; 2011 Apr; 35(4):798-804. PubMed ID: 21312037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate location describe and management of lymph node recurrence after esophagectomy for thoracic esophageal squamous cell carcinoma: a retrospective cohort study.
    Zhao Q; Sun J; Zheng F; Dan Han ; Fu C; Sun H; Liu C; Wang Z; Huang W; Wang R; Li B
    Int J Surg; 2024 Jun; 110(6):3440-3449. PubMed ID: 38498405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
    Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
    BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes and Prognostic Factors of Salvage Treatment for Local Lymph Node Recurrence After Radical Resection of Oesophageal Carcinoma.
    Gu L; Liu Y; Ye H; Gao F; Yin X; Zhao Y; Tian Y
    Cancer Manag Res; 2021; 13():5845-5853. PubMed ID: 34326668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
    Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
    Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.